Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management

Nonsteroidal anti-inflammatory drug exacerbated respiratory disease (N-ERD) is a unique and often clinically severe disease affecting a subgroup of adults with asthma, chronic rhinosinusitis with nasal polyposis, and respiratory reactions with exposure to all cyclooxygenase (COX-1) inhibiting nonste...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Polskie archiwum medycyny wewne̦trznej 2023-09, Vol.133 (9)
Hauptverfasser: Imam, Kamran H, Woessner, Katharine M
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 9
container_start_page
container_title Polskie archiwum medycyny wewne̦trznej
container_volume 133
creator Imam, Kamran H
Woessner, Katharine M
description Nonsteroidal anti-inflammatory drug exacerbated respiratory disease (N-ERD) is a unique and often clinically severe disease affecting a subgroup of adults with asthma, chronic rhinosinusitis with nasal polyposis, and respiratory reactions with exposure to all cyclooxygenase (COX-1) inhibiting nonsteroidal anti-inflammatory drugs (NSAIDS). N-ERD has a high disease burden and is estimated to affect 7% of adult asthmatics and 30% of patients who have both asthma and nasal polyps. The disease is underdiagnosed and under recognized by physicians on a routine basis which leads to a delay in appropriate management. The goal of this review paper is to focus on disease recognition, diagnosis and different modes of up-to-date therapies including medical management, surgical intervention, aspirin desensitization and biologic therapy.
doi_str_mv 10.20452/pamw.16544
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2847341603</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2847341603</sourcerecordid><originalsourceid>FETCH-LOGICAL-c284t-9a9e027634fb2c11275e5e45626c279005fdd1061b82660980350bbc2c418bb03</originalsourceid><addsrcrecordid>eNpNkEtLw0AUhQdRbK2u3EuWgqTOOzPupPiCohtdh5nJTRnJJHUmQfvvjW0VV_fA_TgHPoTOCZ5TzAW9XpvwOSdScH6ApkTpItdcscN_eYJOUnrHWGqmimM0YYXgSmg6RfDctamH2PnKNJlpe5_7tm5MCKbv4iar4rDK4cs4iNb0UGUR0trH_dMnMAluxmBWbZd8GhuqzA0xQttnwbRmBWGMp-ioNk2Cs_2dobf7u9fFY758eXha3C5zRxXvc200YFpIxmtLHSG0ECCAC0mlo4XGWNRVRbAkVlEpsVaYCWyto44TZS1mM3S5613H7mOA1JfBJwdNY1rohlSOKwXjRGI2olc71MUupQh1uY4-mLgpCS63Xssfr-XW60hf7IsHG6D6Y39Fsm_sCXUY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2847341603</pqid></control><display><type>article</type><title>Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management</title><source>EZB-FREE-00999 freely available EZB journals</source><creator>Imam, Kamran H ; Woessner, Katharine M</creator><creatorcontrib>Imam, Kamran H ; Woessner, Katharine M</creatorcontrib><description>Nonsteroidal anti-inflammatory drug exacerbated respiratory disease (N-ERD) is a unique and often clinically severe disease affecting a subgroup of adults with asthma, chronic rhinosinusitis with nasal polyposis, and respiratory reactions with exposure to all cyclooxygenase (COX-1) inhibiting nonsteroidal anti-inflammatory drugs (NSAIDS). N-ERD has a high disease burden and is estimated to affect 7% of adult asthmatics and 30% of patients who have both asthma and nasal polyps. The disease is underdiagnosed and under recognized by physicians on a routine basis which leads to a delay in appropriate management. The goal of this review paper is to focus on disease recognition, diagnosis and different modes of up-to-date therapies including medical management, surgical intervention, aspirin desensitization and biologic therapy.</description><identifier>ISSN: 1897-9483</identifier><identifier>EISSN: 1897-9483</identifier><identifier>DOI: 10.20452/pamw.16544</identifier><identifier>PMID: 37548592</identifier><language>eng</language><publisher>Poland</publisher><ispartof>Polskie archiwum medycyny wewne̦trznej, 2023-09, Vol.133 (9)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37548592$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Imam, Kamran H</creatorcontrib><creatorcontrib>Woessner, Katharine M</creatorcontrib><title>Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management</title><title>Polskie archiwum medycyny wewne̦trznej</title><addtitle>Pol Arch Intern Med</addtitle><description>Nonsteroidal anti-inflammatory drug exacerbated respiratory disease (N-ERD) is a unique and often clinically severe disease affecting a subgroup of adults with asthma, chronic rhinosinusitis with nasal polyposis, and respiratory reactions with exposure to all cyclooxygenase (COX-1) inhibiting nonsteroidal anti-inflammatory drugs (NSAIDS). N-ERD has a high disease burden and is estimated to affect 7% of adult asthmatics and 30% of patients who have both asthma and nasal polyps. The disease is underdiagnosed and under recognized by physicians on a routine basis which leads to a delay in appropriate management. The goal of this review paper is to focus on disease recognition, diagnosis and different modes of up-to-date therapies including medical management, surgical intervention, aspirin desensitization and biologic therapy.</description><issn>1897-9483</issn><issn>1897-9483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkEtLw0AUhQdRbK2u3EuWgqTOOzPupPiCohtdh5nJTRnJJHUmQfvvjW0VV_fA_TgHPoTOCZ5TzAW9XpvwOSdScH6ApkTpItdcscN_eYJOUnrHWGqmimM0YYXgSmg6RfDctamH2PnKNJlpe5_7tm5MCKbv4iar4rDK4cs4iNb0UGUR0trH_dMnMAluxmBWbZd8GhuqzA0xQttnwbRmBWGMp-ioNk2Cs_2dobf7u9fFY758eXha3C5zRxXvc200YFpIxmtLHSG0ECCAC0mlo4XGWNRVRbAkVlEpsVaYCWyto44TZS1mM3S5613H7mOA1JfBJwdNY1rohlSOKwXjRGI2olc71MUupQh1uY4-mLgpCS63Xssfr-XW60hf7IsHG6D6Y39Fsm_sCXUY</recordid><startdate>20230929</startdate><enddate>20230929</enddate><creator>Imam, Kamran H</creator><creator>Woessner, Katharine M</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230929</creationdate><title>Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management</title><author>Imam, Kamran H ; Woessner, Katharine M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c284t-9a9e027634fb2c11275e5e45626c279005fdd1061b82660980350bbc2c418bb03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Imam, Kamran H</creatorcontrib><creatorcontrib>Woessner, Katharine M</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Polskie archiwum medycyny wewne̦trznej</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Imam, Kamran H</au><au>Woessner, Katharine M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management</atitle><jtitle>Polskie archiwum medycyny wewne̦trznej</jtitle><addtitle>Pol Arch Intern Med</addtitle><date>2023-09-29</date><risdate>2023</risdate><volume>133</volume><issue>9</issue><issn>1897-9483</issn><eissn>1897-9483</eissn><abstract>Nonsteroidal anti-inflammatory drug exacerbated respiratory disease (N-ERD) is a unique and often clinically severe disease affecting a subgroup of adults with asthma, chronic rhinosinusitis with nasal polyposis, and respiratory reactions with exposure to all cyclooxygenase (COX-1) inhibiting nonsteroidal anti-inflammatory drugs (NSAIDS). N-ERD has a high disease burden and is estimated to affect 7% of adult asthmatics and 30% of patients who have both asthma and nasal polyps. The disease is underdiagnosed and under recognized by physicians on a routine basis which leads to a delay in appropriate management. The goal of this review paper is to focus on disease recognition, diagnosis and different modes of up-to-date therapies including medical management, surgical intervention, aspirin desensitization and biologic therapy.</abstract><cop>Poland</cop><pmid>37548592</pmid><doi>10.20452/pamw.16544</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1897-9483
ispartof Polskie archiwum medycyny wewne̦trznej, 2023-09, Vol.133 (9)
issn 1897-9483
1897-9483
language eng
recordid cdi_proquest_miscellaneous_2847341603
source EZB-FREE-00999 freely available EZB journals
title Nonsteroidal anti-inflammatory drug-exacerbated respiratory disease: diagnosis and current management
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T03%3A59%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonsteroidal%20anti-inflammatory%20drug-exacerbated%20respiratory%20disease:%20diagnosis%20and%20current%20management&rft.jtitle=Polskie%20archiwum%20medycyny%20wewne%CC%A6trznej&rft.au=Imam,%20Kamran%20H&rft.date=2023-09-29&rft.volume=133&rft.issue=9&rft.issn=1897-9483&rft.eissn=1897-9483&rft_id=info:doi/10.20452/pamw.16544&rft_dat=%3Cproquest_cross%3E2847341603%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2847341603&rft_id=info:pmid/37548592&rfr_iscdi=true